CVS Caremark's second-quarter profit rose 16% as the drugstore operator and pharmacy-benefit manager's profit margins got a boost from new generic drugs.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887324653004578651721033944646.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887324653004578651721033944646.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento